Illumina announced plans to add 50,000 genomes with paired proteomic data to its Alliance for Genomic Discovery (AGD), expanding multi‑omic datasets available to pharma members and aiming to accelerate target identification and biomarker discovery. DeCode Genetics will generate proteomics data using Illumina’s Protein Prep assay; the move adds proteomics to a core human genetics repository. At the same time, Perimeter Medical Imaging AI secured FDA premarket approval for Claire, an AI‑enabled optical coherence tomography device that provides real‑time margin assessment in breast‑conserving surgery. Together, the deals signal faster adoption of integrated omics datasets and AI‑driven intraoperative diagnostics to tighten translational pipelines and surgical outcomes.